Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cronos Group Inc T.CRON

Alternate Symbol(s):  CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is... see more

Recent & Breaking News (TSX:CRON)

Data Projects Canadian Cannabis Legalization Will Spur Stronger Growth

PR Newswire June 25, 2018

Cronos Group Inc. Announces Exclusive Distribution Agreement with Delfarma in Poland

PR Newswire June 25, 2018

Cronos Australia is Granted Manufacturing License

Canada NewsWire June 19, 2018

Analysis: Positioning to Benefit within Canopy Growth, Aurora Cannabis, CannTrust, AbbVie, Cronos Group, and Scotts Miracle-Gro — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire June 15, 2018

Cannabis' Economic Impact to Expand With Emerging Markets

PR Newswire June 14, 2018

Cronos Group Inc. Sets Date for 2018 Annual and Special Meeting of Shareholders

Canada NewsWire June 8, 2018

Thinking about buying stock in Axovant Sciences, Cronos Group, Micron, Netflix or AT&T?

PR Newswire June 7, 2018

Why is Canadian Cannabis Growing So Much Capital in the US?

Jonathon Brown June 5, 2018

Consumer Spending on the Legal Cannabis Market Projected to Grow

PR Newswire June 1, 2018

Cronos Group Inc. To Up List and Begin Trading on Toronto Stock Exchange

Canada NewsWire May 22, 2018

Cronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options

Canada NewsWire May 18, 2018

5 Companies to Watch as Cannabis Legalization Approaches

PR Newswire May 17, 2018

The Value of Legal Cannabis Market Projected to Grow

PR Newswire May 15, 2018

Cronos Group Inc. Announces First Quarter 2018 Results

Canada NewsWire May 15, 2018

Cronos Group Inc to Host Earnings Call

Accesswire May 15, 2018

Legal Cannabis Market on the Rise as Canada and California Impact Sales

PR Newswire May 9, 2018

Cronos Group Inc. to Hold Conference Call on First Quarter 2018 Financial Results

Canada NewsWire May 9, 2018

Increasing Sales of Cannabis Products Projected to Have Positive Economic Effects

PR Newswire May 3, 2018

Cronos Group Inc. Announces Fourth Quarter and Fiscal Year 2017 Results

Canada NewsWire April 30, 2018

Cronos Group Inc. to Hold Conference Call on Fourth Quarter and Fiscal Year 2017 Financial Results

Canada NewsWire April 27, 2018